2cureX AB (OSTO:2CUREX) Other Current Receivables : kr0.00 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB Other Current Receivables?

2cureX AB's Other Current Receivables for the quarter that ended in Sep. 2023 was kr0.00 Mil.

2cureX AB's annual Other Current Receivables declined from Dec. 2020 (kr2.05 Mil) to Dec. 2021 (kr1.41 Mil) and declined from Dec. 2021 (kr1.41 Mil) to Dec. 2022 (kr1.18 Mil).

2cureX AB Other Current Receivables Historical Data

The historical data trend for 2cureX AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2cureX AB Other Current Receivables Chart

2cureX AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Current Receivables

Get a 7-Day Free Trial

1.38

1.36

2.05

1.41

1.18

2cureX AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Current Receivables	Get a 7-Day Free Trial															-	1.18	-	-	-

2cureX AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

2cureX AB Other Current Receivables Related Terms

Thank you for viewing the detailed overview of 2cureX AB's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

2cureX AB (OSTO:2CUREX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

2QE:Germany

Address

Fruebjergvej 3, Copenhagen, DNK, DK-2100

Website

https://www.2curex.com

2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB (OSTO:2CUREX) Headlines

No Headlines